Patient ID,Sample ID,RUN,Sample Date,Reception date,Gender,Date of Birth,Diagnosis date,Country,Nationality,Ethnicity,City of resisdence,NHS number,HIV infection,Pipeline,Hospital Name,Initial Genotype,Genotype,Subtype,Genotyping CORE,Genotyping E1,Genotyping E2,Genotyping P7,Genotyping NS2,Genotyping NS3,Genotyping NS4A,Genotyping NS4B,Genotyping NS5A, Genotyping NS5B,Drug,Manufacturer,Therapy Class,Regime,Treatment date
10,H210220787,NGS91,2021-03-27,2021-04-02,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,University of Dundee Hospital,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,ledipasvir,Gilead,NS5A inhibitor,,2011-06-30
10,H210220787,NGS91,2021-03-27,2021-04-02,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,University of Dundee Hospital,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor,,1988-01-05
10,H210220787,NGS91,2021-03-27,2021-04-02,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,University of Dundee Hospital,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,paritaprevir,AbbVie,NS3A/4A protease inhibitor ,,2011-06-30
10,H210241030,NGS91,2019-04-28,2019-05-04,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,Leeds Teaching Hospitals NHS Trust,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,ledipasvir,Gilead,NS5A inhibitor,,2011-06-30
10,H210241030,NGS91,2019-04-28,2019-05-04,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,Leeds Teaching Hospitals NHS Trust,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor,,1988-01-05
10,H210241030,NGS91,2019-04-28,2019-05-04,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,Leeds Teaching Hospitals NHS Trust,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,paritaprevir,AbbVie,NS3A/4A protease inhibitor ,,2011-06-30
10,H210500364,NGS92,2019-11-01,2019-11-07,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,Leeds Teaching Hospitals NHS Trust,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,ledipasvir,Gilead,NS5A inhibitor,,2011-06-30
10,H210500364,NGS92,2019-11-01,2019-11-07,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,Leeds Teaching Hospitals NHS Trust,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor,,1988-01-05
10,H210500364,NGS92,2019-11-01,2019-11-07,Male,2067-12-14,1998-03-15,Scotland,British,White,Edinburgh ,4662,No,PHE HCV bioinformatics pipeline,Leeds Teaching Hospitals NHS Trust,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,paritaprevir,AbbVie,NS3A/4A protease inhibitor ,,2011-06-30
234,H211361171,NGS96,2020-07-02,2020-07-08,Other,1989-07-31,2004-05-03,USA,British,White,,,Yes,PHE HCV bioinformatics pipeline,Nuffield Health Taunton Hospital,,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a
3,H210180794,NGS91,2020-07-06,2020-07-12,,1984-03-12,1995-04-17,Italy,Italian,Black African,Brighton ,4659,Yes,PHE HCV bioinformatics pipeline,John Radcliffe Hospital,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,2 tablets per day,2011-01-07
3,H210180795,NGS91,2019-11-25,2019-12-01,,1984-03-12,1995-04-17,Italy,Italian,Black African,Brighton ,4659,Yes,PHE HCV bioinformatics pipeline,John Radcliffe Hospital,1a,Check genotyping results by genes: NULL 1a,,,1a,1a,1a,1a,1a,1a,1a,1a,1a,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,2 tablets per day,2011-01-07
